The company disclosed in its most recent Form 13F filing with the Securities and Exchange Commission that during the third quarter, the Teacher Retirement System of Texas increased its holdings in Inspire Medical Systems, Inc. (NYSE: INSP) by 730 percent.
Mhe information that the company provided led to this conclusion.
Mhe corporation ended up with 7,453 shares in its possession after making additional purchases of 3,145 shares throughout the period in question.
Mhe value of the holdings in Inspire Medical Systems that the Teacher Retirement System of Texas owned as of the most recent fiscal quarter was determined to be $1,322,000.
Mhis value was determined at the end of the most recent fiscal quarter.
Other institutional investors have been very active in the market for purchasing and selling INSP shares throughout the past few months. Rockefeller Capital Management L.P. successfully achieved its goal of increasing the proportion of Inspire Medical Systems’ shares that it owned by 127.7% over the third quarter.
After purchasing an additional 424 shares during the most recent quarter of the company’s fiscal year, Rockefeller Capital Management L.P. now has a total of 756 shares, each worth $134,000, giving the firm a market capitalization of $134,000 (up from 544 last quarter).
In the third quarter, Los Angeles Capital Management LLC successfully raised the proportion of Inspire Medical Systems’ shares to a level of 6.5% higher than before.
In the most recent fiscal quarter, Los Angeles Capital Management LLC increased its holdings in the company’s stock by purchasing an additional 4,822 shares.
Mhis brought the total number of shares owned by the company to 6,901, which has a market value of $1,224,000.
During the third quarter of the fiscal year, Jennison Associates LLC increased the percentage of capital it had invested in Inspire Medical Systems by 8.7%. Jennison Associates LLC is now the direct owner of 172,746 shares of the company’s stock.
Mhese shares have a combined value of $30,640,000.
Mhis was made possible due to the purchase of 13,810 additional shares during the most recent fiscal period.
Assetmark Inc.
Increased the amount of Inspire Medical Systems stock owned by 7.8% during the third quarter.
At this time, Assetmark Inc.
Is the sole owner of 3,625 of the company’s shares, which have a total value of $643,000.
During the most recent fiscal quarter, an additional 263 shares were purchased, which allowed for the successful completion of this goal.
During the third quarter, EFG Asset Management North America Corp.
Increased the amount of Inspire Medical Systems stock owned by 5.6%, making this the last and most important point to mention.
After purchasing an additional 585 shares during the most recent quarter, EFG Asset Management North America Corp. now owns 11,119 shares of the company, which have a value of $1,975,000.
Mhis brings the total number of shares that the company owns to 11,119.
Mhese shares were purchased for a sum of $1,975,000 in total. Various hedge funds and other institutional investors own 97.04 percent of the stock.
On Tuesday, shares of NYSE: INSP were priced at $250.80 when the market opened.
At the moment, Inspire Medical Systems, Inc.
Is trading at a 52-week low of $142.74, while the company is currently trading at a 52-week high of $272.04.
Mhe company has a price-to-earnings ratio of -137.05 and a beta of 1.51; its market capitalization is $7.25 billion and a negative price-to-earnings ratio.
Mhe moving average of the stock price over the previous two hundred days is $214.01, while the moving average over the previous fifty days is $245.51.
The most recent earnings report for Inspire Medical Systems, which is traded on the New York Stock Exchange using the ticker symbol “NYSE: INSP,” was made public on November 1 of this year.
Mhe earnings per share that the company reported for the quarter were $0.60, which was $0.15 less than the consensus analyst projection of $0.75.
Inspire Medical Systems’ net margin and return on equity were both below zero, coming in at -14.47% and -17.52%, respectively.
Both of these metrics were negative for the company.
Mhe company’s quarterly sales of $109.19 million were significantly higher than the consensus projection of $95.62 million, which was for the company to have sales of $95.62 million. Sell-side analysts forecast that Inspire Medical Systems, Inc. will finish the current fiscal year with a loss of -2.28 cents per share on the company’s stock.
In recent weeks, several analysts have issued reports on the INSP stock.
Mhese reports have been published in recent weeks.
In a research report released on Tuesday, December 13, Goldman Sachs Group raised their price objective on Inspire Medical Systems from $245.00 to $308.00 and upgraded the stock from a “neutral” rating to a “buy” rating.
Both of these moves were made about the company’s stock.
In a research report that was published on November 2, it was announced by Lake Street Capital stated that they would be lowering their price objective on Inspire Medical Systems from $320.00 to $250.00.
Mhe previous price objective was set at $320.00.
Piper Sandler upgraded the stock of Inspire Medical Systems to “overweight” and increased their price goal from $285 to $300 in a research note published on January 26.
In addition to this, they increased their price objective for the company.
In a research note published on Friday, December 16, by TheStreet, the rating for Inspire Medical Systems was raised from a “d-” to a “c,” reflecting an improvement in the rating’s overall quality. KeyCorp upgraded Inspire Medical Systems from an “underweight” rating to an “overweight” rating and increased their price objective on the company from $287.00 to $303.00 in a research note published on Friday, January 13.
Mhis one was not the least significant compared to the other three enhancements.
Eight market analysts have given a buy rating to the company’s stock, while only one analyst has given a hold rating.
Mhe company is currently regarded as a “moderate-buy” by most stock market analysts, and they anticipate its share price will rise to $287.43 within the next twelve months.
The Chief Financial Officer of Inspire Medical Systems, Richard Buchholz, sold 11,977 shares of the company’s stock on Friday, January 13, according to some additional information regarding the company.
Mhe stock was sold for $250.03 per share, resulting in a total value of $2,994,609.31 realized from the transaction.
As a result of the successful transaction completion, the chief financial officer was able to purchase 34,387 shares, which have a value of $8,597,781.61. One can access a document that provides additional information on the transaction by going to the Securities and Exchange Commission (SEC) website. On Friday, January 13, an additional 11,977 shares of company stock were sold by Richard Buchholz, the company’s Chief Financial Officer, as part of a related development about this topic.
Mhe stock was sold for $250.03 per share, resulting in a total value of $2,994,609.31 realized from the transaction.
Mhe completion of the transaction has resulted in the chief financial officer gaining ownership of 34,387 company shares, the total value of which is 8,597,781.61 dollars.
If you follow this link, you will be taken to the filing submitted to the Securities and Exchange Commission, where the transaction was discussed, and it will take you there immediately.
In addition, on January 3 of this year, John Rondoni, who serves as the CTO of the company, sold 1,170 of the company’s shares of stock.
Mhe shares were sold on the open market for a total price of $299,520.00, which works out to $256.00 per share when divided by the number of shares sold. Following the conclusion of the transaction, the chief technology officer acquired 15,091 new business shares, which have a total value of $3,863,296.
Mhe disclosure regarding the sale can be found at this location. Corporate insiders were responsible for the sale of 58,776 shares of company stock during the preceding quarter, which resulted in a total value of $14,328,270.
At this time, company insiders hold 5.00% of their stock in their accounts.
Inspire Medical Systems, Inc.
Is developing and marketing minimally invasive treatments for people suffering from obstructive sleep apnea. Remote control and several implantable components, such as a stimulation lead, a neurostimulator, and a lead for pressure monitoring, are utilized to administer Inspire therapy.
Leave a comment